Lupin reports 56% rise in Q1 consolidated net profit

30 Jul 2014 Evaluate

Lupin has reported results for first quarter ended June 30, 2014.

The company has posted over two fold jump in its net profit to Rs 1016.73 crore as compared to Rs 410.55 crore for the quarter ended June 30, 2013. Its total income has increased by 52.54% to Rs 3025.55 crore for the quarter under review from Rs 1983.32 crore for the corresponding quarter of the previous year.

On the consolidated basis,the company’s net profit from ordinary activities after tax for the quarter surged 55.77% at Rs 624.74 crore as compared to Rs 401.06 crore for the quarter ended June 30, 2013. Its total income has increased by 30.75% to Rs 3369.73 crore for the quarter under review from Rs 2577.11 crore for the corresponding quarter of the previous year.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2112.00 31.00 (1.49%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×